Cargando…
Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
Severe Acute Respiratory Syndrome (SARS) is a severe febrile respiratory disease caused by the beta genus of human coronavirus, known as SARS-CoV. Last year, 2019-n-CoV (COVID-19) was a global threat for everyone caused by the outbreak of SARS-CoV-2. 3CLpro, chymotrypsin-like protease, is a major cy...
Autores principales: | Paul, Abhik, Sarkar, Arnab, Saha, Sanjukta, Maji, Avik, Janah, Pritha, Kumar Maity, Tapan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254399/ https://www.ncbi.nlm.nih.gov/pubmed/34332853 http://dx.doi.org/10.1016/j.bmc.2021.116301 |
Ejemplares similares
-
Peptidomimetic Small-Molecule
Inhibitors of 3CLPro
Activity and Spike–ACE2 Interaction: Toward Dual-Action Molecules
against Coronavirus Infections
por: Tedesco, Filomena, et al.
Publicado: (2022) -
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022) -
Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2007) -
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
por: Vankadara, Subramanyam, et al.
Publicado: (2021) -
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)